To assess the bile acid composition of cystic bile and serum pharmaco¬kinetics after a 3-week treatment with UDCA and to correlate pharmacokinetic parameters of UDCA in bile and serum during steady state.
see protocol
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Beuers
Amsterdam, Netherlands
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.